SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-028820
Filing Date
2022-08-16
Accepted
2022-08-16 17:06:06
Documents
1
Period of Report
2022-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1564
  Complete submission text file 0000899243-22-028820.txt   3151
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE 5TH FLOOR CAMBRIDGE MA 02140
Business Address
SUMER JACQUELYN L (Reporting) CIK: 0001844824 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39856 | Film No.: 221170981